RHOA and neoplasm: Two recent studies [7, 8] have suggested that tumour cells may adapt to FSS and biomechanical constriction forces by activation of the RhoA-ROCK pathway, a key regulator of cell cytoskeleton in eukaryotic cells involving the signalling protein GTPase RhoA.